Cargando…

Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients

BACKGROUND: The prognostic implication of liver fibrosis in acute coronary syndrome (ACS) patients are scarce. We sought to evaluate whether liver fibrosis scores (LFS) were associated with thrombotic or bleeding events in patients with acute coronary syndrome. METHODS: We included 6386 ACS patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yupeng, Song, Jingjing, Wang, Wenyao, Zhang, Kuo, Yang, Jie, Wen, Jun, Meng, Xiangbin, Gao, Jun, Wang, Jingjia, Shao, Chunli, Tang, Yi-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798679/ https://www.ncbi.nlm.nih.gov/pubmed/36578015 http://dx.doi.org/10.1186/s12959-022-00441-8

Ejemplares similares

Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease
por: Liu, Yupeng, et al.
Publicado: (2022)

Genetically Determined Lifestyle and Cardiometabolic Risk Factors Mediate the Association of Genetically Predicted Age at Menarche With Genetic Predisposition to Myocardial Infarction: A Two-Step, Two-Sample Mendelian Randomization Study
por: Zheng, Jilin, et al.
Publicado: (2022)

Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy
por: Liu, Yupeng, et al.
Publicado: (2023)

The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention
por: Yang, Jie, et al.
Publicado: (2021)

A nomogram predicting 30-day mortality in patients undergoing percutaneous coronary intervention
por: Song, Jingjing, et al.
Publicado: (2022)

CYP2C19 genotype has prognostic value in specific populations following coronary stenting
por: Wang, Wenyao, et al.
Publicado: (2021)

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018)

Elevated HsCRP in Chronic Obstructive Pulmonary Disease: A Prospective Study of Long-Term Outcomes After Percutaneous Coronary Intervention
por: Zheng, Yitian, et al.
Publicado: (2022)

Association Between Lipoprotein(a) and Peri-procedural Myocardial Infarction in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention
por: Liu, Yupeng, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
por: Meng, Xiangbin, et al.
Publicado: (2022)

Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis
por: Yang, Jie, et al.
Publicado: (2022)

High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction
por: Zhou, Qing, et al.
Publicado: (2023)

Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China
por: Zheng, Yitian, et al.
Publicado: (2022)

Bleeding and thrombotic events in post-cardiotomy extracorporeal life support
por: Schaefer, Anne-Kristin, et al.
Publicado: (2023)

Prognostic Impact of Baseline Hemoglobin Levels on Long‐Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions
por: Nagao, Kazuya, et al.
Publicado: (2019)

Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Yang, Jie, et al.
Publicado: (2022)

Prognostic value of free triiodothyronine and N-terminal pro-B-type natriuretic peptide for patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study
por: Wang, Kaihao, et al.
Publicado: (2021)

Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population
por: Meng, Xiangbin, et al.
Publicado: (2018)

SAHA could inhibit TGF-β1/p38 pathway in MI-induced cardiac fibrosis through DUSP4 overexpression
por: Wang, Kaihao, et al.
Publicado: (2021)

Acute myocardial infarction due to traumatic coronary artery dissection: conflicts with thrombotic and bleeding pathologies
por: Yoshida, Chiaki, et al.
Publicado: (2023)

Recurrent coronary thrombotic events in a moderate case of COVID-19
por: Muguerza, Julian, et al.
Publicado: (2021)

Practical Assessment of the Tradeoff between Fatal Bleeding and Coronary Thrombotic Risks using the Academic Research Consortium for High Bleeding Risk Criteria
por: Sotomi, Yohei, et al.
Publicado: (2022)

Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis
por: Murao, Shuhei, et al.
Publicado: (2021)

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review
por: Shapiro, Amy D., et al.
Publicado: (2022)

Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembolism
por: BAI, YUPENG, et al.
Publicado: (2013)

Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
por: Tamargo, Juan, et al.
Publicado: (2022)

Serpins in Hemostasis as Therapeutic Targets for Bleeding or Thrombotic Disorders
por: Bianchini, Elsa P., et al.
Publicado: (2021)

Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
por: Kaptein, Fleur H. J., et al.
Publicado: (2022)

Bleeding and Thrombotic Issues during Extracorporeal Membrane Oxygenation
por: Ranucci, Marco, et al.
Publicado: (2022)

The impact of the stress hyperglycemia ratio on mortality and rehospitalization rate in patients with acute decompensated heart failure and diabetes
por: Zhou, Qing, et al.
Publicado: (2023)

The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021
por: Li, Chen, et al.
Publicado: (2023)

Recurrent Thrombotic Events after Catastrophic Antiphopholipid Syndrome
por: Park, Hayne Cho, et al.
Publicado: (2012)

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases
por: Valke, Lars L. F. G., et al.
Publicado: (2022)

Temporal distribution and biological determinants of thrombotic events after interventions for dialysis vascular access
por: Hsieh, Mu-Yang, et al.
Publicado: (2019)

Impact of the Post-Thrombotic Syndrome on the Arterial Wall of the Lower Limbs
por: Lu, Mingshu, et al.
Publicado: (2022)

Prognostic and Practical Validation of ESC/EACTS High Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in Contemporary PCI Patients
por: Wang, Hao-Yu, et al.
Publicado: (2022)

Thrombotic Events Associated to Aspirin Therapy
por: Doutremepuich, Christian, et al.
Publicado: (2012)

Thrombotic events and COVID-19 vaccines
por: Brazete, C., et al.
Publicado: (2021)

Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
por: Glueck, Charles J., et al.
Publicado: (2018)

Bleeding Risk during Treatment of Acute Thrombotic Events with Subcutaneous LMWH Compared to Intravenous Unfractionated Heparin; A Systematic Review
por: Costantino, Giorgio, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6ar7h10e7396468nb41d2g5q4j